ZTS

ZOETIS INC. (ZTS)

NYSE
$130,17
$+1,31
(+1,02%)
ZOETIS INC. (ZTS) Live Price Chart
Page last updated: 2026-02-12 11:32:10

Key Market Data

$57,36B

$128,53

$249,27

$28,14

$128,67

$+1,31

+1,02%

2K

ZOETIS INC. (ZTS) Stock Price Today

ZOETIS INC. (ZTS) is currently trading at $130,17 as of 2026-02-12 11:32:10, reflecting a +1,02% move ($+1,31) from the previous close.

In the short term, the stock has returned +343,69% over the past four weeks. Over the last 12 months, ZOETIS INC. has recorded a -25,14% price change, indicating a weak performance relative to the broader market.

ZOETIS INC. (ZTS) 7-Day Stock Price Changes

Over the past seven days, ZOETIS INC. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $127,99 to the latest recorded price of $130,17, reflecting an intraday change of +1,02%. Daily movements highlight shifts in trading volume (1.514), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, ZTS has delivered a +343,69% return over the past month and a -25,14% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy ZOETIS INC. (ZTS)

You can buy and trade ZTS on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for ZTS and Execute Your Trade
Step 3: Search for ZTS and Execute Your Trade
Open the trading page, enter ZTS in the search bar, select the amount of ZTS you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is ZOETIS INC. (ZTS)?

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

ZOETIS INC. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
13.800
Sector
PHARMACEUTICAL PREPARATIONS
Company Website

Frequently Asked Questions (FAQ)

1.What is the current share price of ZOETIS INC.?
The latest trading price for ZOETIS INC. (Common Stock) is $ 130,17, compared with a previous closing price of $ 128,67. That means the stock has moved +1,02% so far today. Intraday price updates and recent trading activity for ZTS can be tracked on the live chart and quote section on this page.
2.Is ZOETIS INC. stock going up or down?
Looking at recent performances, ZTS has returned +343,69% over the past month, -14,55% over the last six months and -25,14% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for ZOETIS INC. stock, but keep in mind that past returns do not guarantee future results.
3.Where does ZTS currently sit relative to its 52-week high and low?
In the most recent 52-week period, ZOETIS INC. has traded between a low of $ 115,25 and a high of $ 177,00. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether ZTS is currently nearer the top or the bottom of its one-year trading band.
4.How is ZOETIS INC. classified by sector and industry?
ZOETIS INC. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means ZOETIS INC. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing ZTS’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence ZOETIS INC.’s performance.
5.Where is ZOETIS INC. listed and how large is it by market value?
ZOETIS INC. is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 57,36B, the company is classified as a Large-cap stock. Market cap gives a quick sense of ZOETIS INC.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does ZTS's EPS tell investors about its profitability?
Trailing-twelve-month EPS of $ 6,02 summarises how much profit ZOETIS INC. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track ZOETIS INC.'s financial performance over time?
To follow ZOETIS INC.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how ZTS is performing and how the market is responding.
8.When is ZOETIS INC. expected to report earnings?
ZOETIS INC.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for ZTS, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in ZOETIS INC.'s earnings reports?
ZOETIS INC.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether ZTS is meeting, beating or missing expectations.
10.How can I stay informed about ZOETIS INC.'s results and guidance?
You can stay up to date on ZOETIS INC. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for ZTS on this page helps you see how new information is being reflected in the stock.
11.Does ZOETIS INC. pay a regular cash dividend to its shareholders?
ZOETIS INC. Paying. Based on the latest information, the stock has an indicated annual cash dividend of $ 1,98 per share and a current dividend yield of 0,0152 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor ZTS's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for ZTS?
Based on the latest earnings data, ZTS has a dividend yield of 0,0152 and a dividend payout ratio of 0,3287. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether ZOETIS INC. is an attractive income stock. The dividend payout ratio measures what percentage of earnings ZOETIS INC. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is ZOETIS INC.?
ZOETIS INC. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is ZTS valued in terms of P/E ratio and EPS?
ZOETIS INC. currently trades at a price-to-earnings (P/E) ratio of 21,39, based on trailing-twelve-month earnings per share (EPS) of $ 6,02. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of ZOETIS INC.'s earnings. Comparing ZTS's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as ZOETIS INC.

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

ZTS-to-USD Calculator

Amount

ZTS
ZTS
USD
USD

1 ZTS = 130,164 USD